RARE / USDC

RARE / TRY

RARE / USDT

RARE / BTC

SOMI / USDC

SOMI / USDT

SOMI / TRY

SOMI / FDUSD

SOMI / BNB

PROM / USDT

BAKE / BTC

BAKE / USDT

BAKE / TRY

HIFI / USDT

LA / FDUSD

SLF / TRY

SLF / USDC

SLF / USDT

SLF / BTC

GALA / BTC

QMS MEDI LTD

TAURIAN MPS LIMITED

RAVINDER HEIGHTS LIMITED

REDINGTON LIMITED

LAXMI DENTAL LIMITED

PAVNA INDUSTRIES LIMITED

SINDHU TRADE LINKS LTD

MIRZA INTERNATIONAL LIMIT

DUCON INFRATECHNOLOGIES L

ALLIED DIGITAL SERV. LTD

GODFREY PHILLIPS INDIA LT

SHRADHA INFRAPROJECTS LTD

JITF INFRALOGISTICS LTD

APRAMEYA ENGINEERING LTD

RITE ZONE CHEMCON IND LTD

MY MUDRA FINCORP LIMITED

LE TRAVENUES TECHNOLOGY L

P. E. ANALYTICS LIMITED

MAGNUM VENTURES LTD.

ANIK INDUSTRIES LTD

Click here to get full coverage on Kilitch Drugs Announces Details for 33rd AGM - TipRanks

Kilitch Drugs Announces Details for 33rd AGM  TipRanks

Kilitch Drugs Announces Details for 33rd AGM - TipRanks

Click here to get full coverage on Kilitch Drugs Adjusts Valuation Amid Mixed Financial Performance and Market Sentiment - Markets Mojo

Kilitch Drugs Adjusts Valuation Amid Mixed Financial Performance and Market Sentiment  Markets Mojo

Kilitch Drugs Adjusts Valuation Amid Mixed Financial Performance and Market Sentiment - Markets Mojo

Click here to get full coverage on Kilitch Drugs Approves ₹50 Crore Rights Issue at ₹357/share; Board Sets July 15 as Record Date - HDFC Sky

Kilitch Drugs Approves ₹50 Crore Rights Issue at ₹357/share; Board Sets July 15 as Record Date  HDFC Sky

Kilitch Drugs Approves ₹50 Crore Rights Issue at ₹357/share; Board Sets July 15 as Record Date - HDFC Sky

Click here to get full coverage on Kilitch Drugs Announces 33rd AGM with Key Leadership Reappointments - TipRanks

Kilitch Drugs Announces 33rd AGM with Key Leadership Reappointments  TipRanks

Kilitch Drugs Announces 33rd AGM with Key Leadership Reappointments - TipRanks

Click here to get full coverage on Impressive Earnings May Not Tell The Whole Story For Kilitch Drugs (India) (NSE:KILITCH) - simplywall.st

Impressive Earnings May Not Tell The Whole Story For Kilitch Drugs (India) (NSE:KILITCH)  simplywall.st

Impressive Earnings May Not Tell The Whole Story For Kilitch Drugs (India) (NSE:KILITCH) - simplywall.st

Click here to get full coverage on Kilitch Drugs posts consolidated Q4 FY25 PAT at Rs. 10.21 Cr - Indian Pharma Post

Kilitch Drugs posts consolidated Q4 FY25 PAT at Rs. 10.21 Cr  Indian Pharma Post

Kilitch Drugs posts consolidated Q4 FY25 PAT at Rs. 10.21 Cr - Indian Pharma Post

Click here to get full coverage on Kilitch Drugs eyes Rs 1,000 crore revenue with Khopoli expansion regulated market entry - Moneycontrol

Kilitch Drugs eyes Rs 1,000 crore revenue with Khopoli expansion regulated market entry  Moneycontrol

Kilitch Drugs eyes Rs 1,000 crore revenue with Khopoli expansion regulated market entry - Moneycontrol

Click here to get full coverage on Kilitch Drugs to raise around Rs 50 Cr via rights issue - BioSpectrum India

Kilitch Drugs to raise around Rs 50 Cr via rights issue  BioSpectrum India

Kilitch Drugs to raise around Rs 50 Cr via rights issue - BioSpectrum India

Click here to get full coverage on Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share - Express Pharma

Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share  Express Pharma

Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share - Express Pharma

Click here to get full coverage on Kilitch Drugs post ₹10 crore net profit in Q4 FY25 - ET Pharma

Kilitch Drugs post ₹10 crore net profit in Q4 FY25  ET Pharma

Kilitch Drugs post ₹10 crore net profit in Q4 FY25 - ET Pharma

Click here to get full coverage on This small-cap pharma firm is eyeing a pie of the growing weight-loss drug market - Business Today

This small-cap pharma firm is eyeing a pie of the growing weight-loss drug market  Business Today

This small-cap pharma firm is eyeing a pie of the growing weight-loss drug market - Business Today

Click here to get full coverage on Kilitch Drugs Approves Rights Issue to Strengthen Capital - TipRanks

Kilitch Drugs Approves Rights Issue to Strengthen Capital  TipRanks

Kilitch Drugs Approves Rights Issue to Strengthen Capital - TipRanks

Click here to get full coverage on Kilitch Drugs (India) Limited's (NSE:KILITCH) Popularity With Investors Is Clear - simplywall.st

Kilitch Drugs (India) Limited's (NSE:KILITCH) Popularity With Investors Is Clear  simplywall.st

Kilitch Drugs (India) Limited's (NSE:KILITCH) Popularity With Investors Is Clear - simplywall.st

Click here to get full coverage on Kilitch Drugs Approaches 52-Week High Amid Strong Financial Performance and Market Resilience - Markets Mojo

Kilitch Drugs Approaches 52-Week High Amid Strong Financial Performance and Market Resilience  Markets Mojo

Kilitch Drugs Approaches 52-Week High Amid Strong Financial Performance and Market Resilience - Markets Mojo

Click here to get full coverage on Kilitch Drugs Approves ₹50 Cr Rights Issue for Expansion - HDFC Sky

Kilitch Drugs Approves ₹50 Cr Rights Issue for Expansion  HDFC Sky

Kilitch Drugs Approves ₹50 Cr Rights Issue for Expansion - HDFC Sky

Click here to get full coverage on Despite global volatility India’s pharma exports continue to demonstrate steady resilience - Express Pharma

Despite global volatility India’s pharma exports continue to demonstrate steady resilience  Express Pharma

Despite global volatility India’s pharma exports continue to demonstrate steady resilience - Express Pharma

Click here to get full coverage on Kilitch Drugs Announces AGM Amidst Market Adjustments - TipRanks

Kilitch Drugs Announces AGM Amidst Market Adjustments  TipRanks

Kilitch Drugs Announces AGM Amidst Market Adjustments - TipRanks

Click here to get full coverage on Kilitch Drugs Achieves All-Time High Stock Price Amid Strong Growth Metrics - Markets Mojo

Kilitch Drugs Achieves All-Time High Stock Price Amid Strong Growth Metrics  Markets Mojo

Kilitch Drugs Achieves All-Time High Stock Price Amid Strong Growth Metrics - Markets Mojo

Click here to get full coverage on Kilitch Drugs Postpones Rights Issue Share Credit and Listing Dates - TipRanks

Kilitch Drugs Postpones Rights Issue Share Credit and Listing Dates  TipRanks

Kilitch Drugs Postpones Rights Issue Share Credit and Listing Dates - TipRanks

Click here to get full coverage on Kilitch Drugs Adjusts Evaluation Amid Strong Growth and Management Efficiency Challenges - Markets Mojo

Kilitch Drugs Adjusts Evaluation Amid Strong Growth and Management Efficiency Challenges  Markets Mojo

Kilitch Drugs Adjusts Evaluation Amid Strong Growth and Management Efficiency Challenges - Markets Mojo

Click here to get full coverage on FDA lambasts Kilitch for unsanitary manufacturing conditions and issues warning letter to Natco, too - Fierce Pharma

FDA lambasts Kilitch for unsanitary manufacturing conditions and issues warning letter to Natco, too  Fierce Pharma

FDA lambasts Kilitch for unsanitary manufacturing conditions and issues warning letter to Natco, too - Fierce Pharma

Click here to get full coverage on Kilitch Drugs Reports Strong Growth Amid Challenges in Management Efficiency - Markets Mojo

Kilitch Drugs Reports Strong Growth Amid Challenges in Management Efficiency  Markets Mojo

Kilitch Drugs Reports Strong Growth Amid Challenges in Management Efficiency - Markets Mojo

Click here to get full coverage on Pharma stock jumps 5% after board approves rights issue of 13,98,463 shares; Check record date - Trade Brains

Pharma stock jumps 5% after board approves rights issue of 13,98,463 shares; Check record date  Trade Brains

Pharma stock jumps 5% after board approves rights issue of 13,98,463 shares; Check record date - Trade Brains

Click here to get full coverage on Kilitch Drugs (india) Rights Issue 2025 Date, Price, Allotment, Ratio - IPO Watch

Kilitch Drugs (india) Rights Issue 2025 Date, Price, Allotment, Ratio  IPO Watch

Kilitch Drugs (india) Rights Issue 2025 Date, Price, Allotment, Ratio - IPO Watch

Click here to get full coverage on Bhavin Mukund Mehta appointed as vice chairman of Pharmexcil - Pharmabiz.com

Bhavin Mukund Mehta appointed as vice chairman of Pharmexcil  Pharmabiz.com

Bhavin Mukund Mehta appointed as vice chairman of Pharmexcil - Pharmabiz.com

Click here to get full coverage on Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 30 April 2025 - Mint

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 30 April 2025  Mint

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 30 April 2025 - Mint

Click here to get full coverage on Indian manufacturer recalls eyedrops previously cited in FDA warning - PBS

Indian manufacturer recalls eyedrops previously cited in FDA warning  PBS

Indian manufacturer recalls eyedrops previously cited in FDA warning - PBS

Click here to get full coverage on Pharma stock jumps 10% after reporting company’s net profits grow by 185% YoY - Trade Brains

Pharma stock jumps 10% after reporting company’s net profits grow by 185% YoY  Trade Brains

Pharma stock jumps 10% after reporting company’s net profits grow by 185% YoY - Trade Brains

Click here to get full coverage on Bhavin Mukund Mehta steps in as Vice-Chairman of Pharmexcil - BioSpectrum India

Bhavin Mukund Mehta steps in as Vice-Chairman of Pharmexcil  BioSpectrum India

Bhavin Mukund Mehta steps in as Vice-Chairman of Pharmexcil - BioSpectrum India

Click here to get full coverage on Kilitch Drugs Rights Issue Date, Price, Market Lot, Subscription 2025 - IPO Central

Kilitch Drugs Rights Issue Date, Price, Market Lot, Subscription 2025  IPO Central

Kilitch Drugs Rights Issue Date, Price, Market Lot, Subscription 2025 - IPO Central

Click here to get full coverage on FDA Investigation Leads to Another Large Recall of Eye Drop Products - Medical Professionals Reference

FDA Investigation Leads to Another Large Recall of Eye Drop Products  Medical Professionals Reference

FDA Investigation Leads to Another Large Recall of Eye Drop Products - Medical Professionals Reference

Click here to get full coverage on More Eye Drops Recalled After FDA Warning - AARP

More Eye Drops Recalled After FDA Warning  AARP

More Eye Drops Recalled After FDA Warning - AARP

Click here to get full coverage on Pharmexcil appoints Bhavin Mehta as Vice-Chairman - Express Pharma

Pharmexcil appoints Bhavin Mehta as Vice-Chairman  Express Pharma

Pharmexcil appoints Bhavin Mehta as Vice-Chairman - Express Pharma

Click here to get full coverage on Indian eyedrop maker issues recall of various eye drops in US for potential safety reasons - The Economic Times

Indian eyedrop maker issues recall of various eye drops in US for potential safety reasons  The Economic Times

Indian eyedrop maker issues recall of various eye drops in US for potential safety reasons - The Economic Times

Click here to get full coverage on Tainted eyedrops pulled by CVS, Target made by barefoot workers in India: report - New York Post

Tainted eyedrops pulled by CVS, Target made by barefoot workers in India: report  New York Post

Tainted eyedrops pulled by CVS, Target made by barefoot workers in India: report - New York Post

Click here to get full coverage on USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant - The Economic Times

USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant  The Economic Times

USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant - The Economic Times

Click here to get full coverage on Another eye drop recall pulls 28 products off of CVS, Rite Aid, Target and Walmart shelves after FDA warning - CBS News

Another eye drop recall pulls 28 products off of CVS, Rite Aid, Target and Walmart shelves after FDA warning  CBS News

Another eye drop recall pulls 28 products off of CVS, Rite Aid, Target and Walmart shelves after FDA warning - CBS News

Click here to get full coverage on A temporary US tariff relief for Indian pharma sector - BioSpectrum India

A temporary US tariff relief for Indian pharma sector  BioSpectrum India

A temporary US tariff relief for Indian pharma sector - BioSpectrum India

Click here to get full coverage on Bhavin Mukund Mehta named as Vice-Chairman of Pharmexcil - MediaNews4U

Bhavin Mukund Mehta named as Vice-Chairman of Pharmexcil  MediaNews4U

Bhavin Mukund Mehta named as Vice-Chairman of Pharmexcil - MediaNews4U

Click here to get full coverage on Pharma stock jumps 14% after reporting 7718% QoQ increase in net profits - Trade Brains

Pharma stock jumps 14% after reporting 7718% QoQ increase in net profits  Trade Brains

Pharma stock jumps 14% after reporting 7718% QoQ increase in net profits - Trade Brains

Click here to get full coverage on Kilitch Healthcare recalls eyedrops made for CVS, Walmart - Mint

Kilitch Healthcare recalls eyedrops made for CVS, Walmart  Mint

Kilitch Healthcare recalls eyedrops made for CVS, Walmart - Mint

Click here to get full coverage on Kilitch Healthcare India recalls various eye drops in US over potential safety concerns - CNBC TV18

Kilitch Healthcare India recalls various eye drops in US over potential safety concerns  CNBC TV18

Kilitch Healthcare India recalls various eye drops in US over potential safety concerns - CNBC TV18

Click here to get full coverage on Facility with barefoot workers made CVS, Target, Walmart eye drops in second recall - Miami Herald

Facility with barefoot workers made CVS, Target, Walmart eye drops in second recall  Miami Herald

Facility with barefoot workers made CVS, Target, Walmart eye drops in second recall - Miami Herald

Click here to get full coverage on USFDA issues 'warning letter' to Kilitch Healthcare over GMP violation - Business Standard

USFDA issues 'warning letter' to Kilitch Healthcare over GMP violation  Business Standard

USFDA issues 'warning letter' to Kilitch Healthcare over GMP violation - Business Standard

Click here to get full coverage on Kilitch Healthcare recalls eye drops amid U.S. FDA investigators finding insanitary conditions - The Hindu

Kilitch Healthcare recalls eye drops amid U.S. FDA investigators finding insanitary conditions  The Hindu

Kilitch Healthcare recalls eye drops amid U.S. FDA investigators finding insanitary conditions - The Hindu

Click here to get full coverage on 4 insights to kick-start your day, featuring Kilitch’s decision to pull out eyedrops in the US - The Economic Times

4 insights to kick-start your day, featuring Kilitch’s decision to pull out eyedrops in the US  The Economic Times

4 insights to kick-start your day, featuring Kilitch’s decision to pull out eyedrops in the US - The Economic Times

Click here to get full coverage on Kilitch Drugs (India) Ltd Surges in Stock Market, Outperforms Sector by 1.77% - Markets Mojo

Kilitch Drugs (India) Ltd Surges in Stock Market, Outperforms Sector by 1.77%  Markets Mojo

Kilitch Drugs (India) Ltd Surges in Stock Market, Outperforms Sector by 1.77% - Markets Mojo

Click here to get full coverage on Kilitch Drug India's subsidiary wins tender in Ethiopia - Indian Pharma Post

Kilitch Drug India's subsidiary wins tender in Ethiopia  Indian Pharma Post

Kilitch Drug India's subsidiary wins tender in Ethiopia - Indian Pharma Post

Click here to get full coverage on Kilitch Drugs earmarks Rs. 100 crore as part of its expansion - Indian Pharma Post

Kilitch Drugs earmarks Rs. 100 crore as part of its expansion  Indian Pharma Post

Kilitch Drugs earmarks Rs. 100 crore as part of its expansion - Indian Pharma Post

Click here to get full coverage on Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan - Medical Dialogues

Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan  Medical Dialogues

Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan - Medical Dialogues

Click here to get full coverage on Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India - Indian Pharma Post

Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India  Indian Pharma Post

Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India - Indian Pharma Post

Click here to get full coverage on Kilitch Drugs (India) Limited’s Subsidiary Won Tender Issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia - ThePrint

Kilitch Drugs (India) Limited’s Subsidiary Won Tender Issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia  ThePrint

Kilitch Drugs (India) Limited’s Subsidiary Won Tender Issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia - ThePrint

Click here to get full coverage on Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan - Business Standard

Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan  Business Standard

Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan - Business Standard

Click here to get full coverage on Kilitch Drugs Manufacturing Plant - Pharmaceutical Technology

Kilitch Drugs Manufacturing Plant  Pharmaceutical Technology

Kilitch Drugs (India) Limited (KILITCH)

Price Chart

Key Statistics

Technicals

About KILITCH

Latest News

Kilitch Drugs Announces Details for 33rd AGM - TipRanks

Kilitch Drugs Adjusts Valuation Amid Mixed Financial Performance and Market Sentiment - Markets Mojo

Kilitch Drugs Approves ₹50 Crore Rights Issue at ₹357/share; Board Sets July 15 as Record Date - HDFC Sky

Advanced Charts

Top Gainers

Top Losers